Alexion Pharmaceutical Inc. buy ValueFreak
Start price
31.03.20
/
50%
€81.44
Target price
08.04.20
€95.00
Performance (%)
10.79%
End price
08.04.20
€90.23
Summary
This prediction ended on 08.04.20 with a price of €90.23. The prediction had a final performance of 10.79%. ValueFreak has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alexion Pharmaceutical Inc. | - | - | - | - |
iShares Core DAX® | 2.821% | -1.953% | 15.071% | 11.862% |
iShares Nasdaq 100 | 5.285% | -5.092% | 29.254% | 40.075% |
iShares Nikkei 225® | 3.687% | -4.221% | 14.286% | 6.629% |
iShares S&P 500 | 3.577% | -2.240% | 25.546% | 38.398% |
According to ValueFreak what are the pros and cons of Alexion Pharmaceutical Inc. for the foreseeable future?
Pros
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Good rating
Very positive Cash Flow expected
High Investments for future growth
Strong uniques
Differentiated customer and product portfolio
Growths much faster than the competition
Sustainability is very important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Very small cyclical dependencies
Known brand
Very Future proof/growth oriented business model
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Cons
Low dividend yield expected
Comments by ValueFreak for this prediction
In the thread Alexion Pharmaceutical Inc. diskutieren
Finanziell sehr solide aufgestellt - habe heute gekauft.,
https://ir.alexion.com/static-files/c1e8aa68-bbb7-4745-9a73-6efce71e29be
https://ir.alexion.com/static-files/c1e8aa68-bbb7-4745-9a73-6efce71e29be
In the thread Trading Alexion Pharmaceutical Inc.
Buy beendet
Stopped prediction by ValueFreak for Alexion Pharmaceutical Inc.
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€89.92
30.07.20
30.07.20
€125.00
04.11.21
04.11.21
44.97%
21.01.21
21.01.21
Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year